Get short, timely messages from Insight Pharma .

Twitter is a rich source of instantly updated information. It's easy to stay updated on an incredibly wide variety of topics. Join today and follow @CHIReports.

Get updates via SMS by texting follow CHIReports to 40404 in the United States
Codes for other countries

Two-way (sending and receiving) short codes:
Country Code For customers of
Australia
  • 0198089488 Telstra
Canada
  • 21212 (any)
United Kingdom
  • 86444 Vodafone, Orange, 3, O2
Indonesia
  • 89887 AXIS, 3, Telkomsel
Ireland
  • 51210 O2
India
  • 53000 Bharti Airtel, Videocon
Jordan
  • 90903 Zain
New Zealand
  • 8987 Vodafone, Telecom NZ
United States
  • 40404 (any)

CHIReports

  1. Buy this #HCA report & receive the High-Content Analysis Course DVD FREE! bit.ly/GZo37E #pharma #biotech
  2. Trends in #biomarker partnering deals bit.ly/MNiK0A #pharma #biotech
  3. #Medical Imaging Information Systems Market to 2017 bit.ly/LhD74l #ehealth #IT
  4. New Emerging R&D and #Clinical Trial Locations bit.ly/JVHLqG #pharma #biotech
  5. #Lung #Cancer Trial Combines #Blood Test & #Imaging bit.ly/JA7GEg @eCliniqua #biotech #pharma
  6. Free Webinar: Bridging #Enterprise & #Cloud #Infrastructure 5/30 at 1:30pmEST bit.ly/LqIhqM #epharma #digpharma #bioinformatics
  7. Breaking the Gene Therapy Barrier for Life-Threatening Red Blood Cell Disorders bit.ly/KSeKav #pharma #biotech
  8. Emerging #Pharmaceutical Market in China bit.ly/L93pWv #pharma #biotech
  9. The first hematological #cancer to be identified was Hodgkin’s disease, or Hodgkin lymphoma, in 1832. bit.ly/zOo6xh #pharma #biotech
  10. New! Backup Compound Strategies: Commercial and Tactical Considerations Report: lnkd.in/RTXVFq
  11. Interested in #Biosimilars? New market reports added here bit.ly/GBMQBP #pharma #biotech
  12. Expert interviews on modulating the PI3K/Akt/mTOR cascade bit.ly/HtbIM3 #pharma #biotech
  13. Advances in Ion Channel #Drug #Discovery bit.ly/JmUCgK #pharma #biotech
  14. Product Profiles: Non-Small Cell #Lung #Cancer bit.ly/L3hN2w #pharma #biotech
  15. What’s the next big thing in the global Cushing's Syndrome Therapeutics market landscape? bit.ly/IyibUx #pharma #biotech
  16. Why have certain LCM strategies been successful whereas others have failed? bit.ly/LjmX9V #pharma #biotech
  17. Case histories that illustrate the use of backup compounds in practice bit.ly/Jpoehx #drug #pharma #biotech
  18. A snapshot of the global therapeutic scenario for Spinal Cord Injury. bit.ly/IFTx6U #pharma #biotech
  19. Review of the use of #CER in the US, with particular attention to Medicaid and Medicare bit.ly/ySfVAh #health #pharma
  20. The #CMO Market Outlook to 2017 bit.ly/K4uGra #biotech #pharma